Globeflex Capital’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-5,146
Closed -$506K 468
2018
Q2
$506K Sell
5,146
-1,453
-22% -$163K 0.1% 298
2018
Q1
$735K Buy
6,599
+5,136
+351% +$576K 0.16% 227
2017
Q4
$150K Hold
1,463
0.04% 327
2017
Q3
$138K Hold
1,463
0.04% 316
2017
Q2
$114K Sell
1,463
-1,690
-54% -$127K 0.03% 346
2017
Q1
$253K Hold
3,153
0.06% 339
2016
Q4
$248K Sell
3,153
-136
-4% -$10.6K 0.06% 333
2016
Q3
$256K Buy
+3,289
New +$239K 0.06% 318
2014
Q4
Sell
-21,800
Closed -$749K 609
2014
Q3
$749K Sell
21,800
-53
-0.2% -$1.87K 0.08% 256
2014
Q2
$800K Hold
21,853
0.09% 248
2014
Q1
$736K Buy
+21,853
New +$721K 0.08% 256

Other funds holding CMD

Globeflex Capital's CMD Position: Q3 2018 in Review

Globeflex Capital sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 5,146 shares — an estimated $506K sold.

Globeflex Capital first reported a position in CMD in Q1 2014 and held it in 11 quarters. The position peaked at $800K in Q2 2014. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Globeflex Capital reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Globeflex Capital sold 5,146 Cantel Medical Corporation shares in Q3 2018, an estimated $506K.
  • Globeflex Capital first reported a position in Cantel Medical Corporation in Q1 2014 and held it in 11 quarters.
  • Globeflex Capital's Cantel Medical Corporation position peaked at $800K in Q2 2014.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Globeflex Capital's 13F filing for Q3 2018, filed 9 Nov 2018.